Literature DB >> 629360

Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites.

S M Muldoon, P M Vanhoutte, G M Tyce.   

Abstract

To examine the disposition of [3H]norepinephrine ([3H]NE) in adrenergically innervated veins, helical strips of canine saphenous veins were incubated in Krebs-Ringer solution containing D,L[3H]NE (2 X 10(-7) M) for 2 h. [3H]NE and its metabolites were measured in extracts of veins and in superfusate (Krebs-Ringer) collected during basal conditions and during release of [3H]NE evoked by electrical stimulation (1-8 Hz), tyramine (5 X 10(-6) to 5 X 10(-4) M), or high concentrations of potassium (35-100 meq/liter). During basal conditions, the efflux from veins comprised mainly metabolits of [3H]NE, especially 3,4-dihydroxphenylglycol (DOPEG) and 3-methoxy-4-hydroxyphenylglycol (MOPEG); this pattern was unchanged by cocaine treatment, and monoamine oxidase inhibition reduced the formation of DOPEG. During evoked release of NE, the major metabolites in the perfusate were DOPEG, MOPEG, and normetanephrine, and their proportions differed with the stimulus used: O-methylated metabolites in the perfusate always increased more than did the deaminated catechol compounds; DOPEG and MOPEG were released in greater amounts than the corresponding acids; and cocaine treatment caused a higher content of all metabolites except DOPEG. 3-Methoxy-4-hydroxymandelic acid was also formed by the vein but was retained in the tissue.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629360     DOI: 10.1152/ajpheart.1978.234.3.H235

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  The effect of labetalol on the release of [3H]-labelled noradrenaline and its metabolites from dog isolated saphenous vein [proceedings].

Authors:  G M Drew; G P Levy; A T Sullivan
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

2.  Role of neuronal uptake in the disposition of released [3H]-noradrenaline in the dog's saphenous vein [proceedings].

Authors:  P M Vanhoutte; T J Verbeuren
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

3.  Deamination of released 3H-noradrenaline in the canine saphenous vein.

Authors:  T J Verbeuren; P M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

4.  Cocaine and neuronal uptake in the canine saphenous vein.

Authors:  T J Verbeuren; P M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

5.  Metabolism of endogenous and exogenous noradrenaline in the rabbit perfused heart.

Authors:  H Majewski; L Hedler; A Steppeler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

6.  Metabolism of endogenous and exogenous noradrenaline in guinea-pig atria.

Authors:  K Starke; L Hedler; A Steppeler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

7.  Effects of hypoxia on noradrenaline release and neuronal reuptake in isolated rabbit thoracic aortic strips.

Authors:  K Lee; S Miwa; Y Hayashi; K Koshimura; M Fujiwara; Y Orii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

8.  Modulation of the concentration of noradrenaline at the neuro-effector junction in human saphenous vein.

Authors:  W Janssens; R Verhaeghe
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.